title: Overexpression of HMGB3 protein promotes cell proliferation, migration and is associated with poor prognosis in urinary bladder cancer patients.
abstract: Human urinary bladder cancer (UBC) is the fourth most common cancer and the eighth most common cause of cancer death in the USA. High mobility group box 3 (HMGB3), a member of a family of proteins containing one or more high mobility group DNA binding motifs, was reported to be overexpressed in a variety of human cancers. However, the expression and role of HMGB3 in human UBC remains unclear. Here, we found that UBC patients had upregulated HMGB at both mRNA and protein levels. Immunochemistry (IHC) evaluation of HMGB3 expression in 113 UBC clinical specimens showed that high expression of HMGB3 had positive correlation with UBC tumor size (P = 0.019), tumor WHO grade (P = 0.031), stage (P = 0.028), and lymph node metastasis (P = 0.017). Moreover, patients with higher HMGB3 expression showed a poorer overall survival rate than those with relatively low HMGB3 (P = 0.0079, log-rank test). Multivariate analysis revealed that HMGB3 expression is an independent prognostic marker. The UBC cancer cell proliferation and migration ability were measured by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) and wound healing assays, respectively. RNA interference of HMGB3 in UBC cell lines inhibited cancer cell growth and migration, along with the downregulation of PCNA and MMP2 protein levels. In sum, our data suggests HMGB3 may serve as an important oncoprotein and indicate that overexpression of HMGB3 in UBC could be used as a potential prognostic marker.
authors: Department of Emergency Medicine, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu, 223300, China.
authors: Minghui
authors: M
authors: Li
authors: Yong
authors: Y
authors: Cai
authors: Hongmei
authors: H
authors: Zhao
authors: Zongyuan
authors: Z
authors: Xu
authors: Qingsong
authors: Q
authors: Sun
authors: Man
authors: M
authors: Luo
authors: Lizhi
authors: L
authors: Gu
authors: Min
authors: M
authors: Meng
authors: Xiang
authors: X
authors: Han
authors: Hong
authors: H
authors: Sun
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000096:biosynthesis* / Q000235:genetics; D049109:Cell Proliferation / Q000235:genetics*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D025765:HMGB3 Protein / Q000096:biosynthesis* / Q000235:genetics; D006801:Humans; D053208:Kaplan-Meier Estimate; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D001749:Urinary Bladder Neoplasms / Q000235:genetics* / Q000473:pathology
chemical_list: D014408:Biomarkers, Tumor; D025765:HMGB3 Protein
references: Cell Stem Cell. 2009 Feb 6;4(2):129-40
references: 19200802
references: Med Oncol. 2011 Jun;28(2):565-71
references: 20300976
references: Cancer Res. 2004 Jun 1;64(11):4040-8
references: 15173019
references: Lancet. 2009 Jul 18;374(9685):239-49
references: 19520422
references: PLoS One. 2013 Oct 02;8(10):e76402
references: 24098490
references: Onco Targets Ther. 2011;4:97-113
references: 21792316
references: Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13783-8
references: 16945912
references: Biochim Biophys Acta. 2010 Jan-Feb;1799(1-2):101-13
references: 20123072
references: Nat Genet. 2008 May;40(5):499-507
references: 18443585
references: APMIS. 1992 Nov;100(11):988-92
references: 1361755
references: Tumour Biol. 2014 Nov;35(11):11505-11
references: 25128061
references: Nat Rev Urol. 2011 Oct 11;8(11):631-42
references: 21989305
references: Tumour Biol. 2013 Oct;34(5):2599-603
references: 23609034
references: World J Gastroenterol. 2012 Dec 28;18(48):7319-26
references: 23326140
references: Br J Cancer. 2013 Apr 16;108(7):1470-9
references: 23511556
references: Nat Rev Cancer. 2005 Sep;5(9):713-25
references: 16110317
references: Biochem Pharmacol. 2010 Oct 15;80(8):1201-9
references: 20615395
references: BJU Int. 2013 Aug;112(3):404-6
references: 23826845
references: Genet Mol Res. 2013 Dec 02;12(4):6032-9
references: 24338397
references: Tumour Biol. 2014 Oct;35(10):9777-85
references: 24981246
references: CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29
references: 24399786
references: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references: 21296855
references: Leukemia. 2010 Mar;24(3):654-8
references: 19956199